ES8304559A1 - "procedimiento para la fabricacion de sales de naftidrofurilo". - Google Patents

"procedimiento para la fabricacion de sales de naftidrofurilo".

Info

Publication number
ES8304559A1
ES8304559A1 ES512819A ES512819A ES8304559A1 ES 8304559 A1 ES8304559 A1 ES 8304559A1 ES 512819 A ES512819 A ES 512819A ES 512819 A ES512819 A ES 512819A ES 8304559 A1 ES8304559 A1 ES 8304559A1
Authority
ES
Spain
Prior art keywords
acid
acetone
ethyl acetate
therapeutic use
citric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES512819A
Other languages
English (en)
Other versions
ES512819A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9258433&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8304559(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of ES512819A0 publication Critical patent/ES512819A0/es
Publication of ES8304559A1 publication Critical patent/ES8304559A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Furan Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE SALES DE NAFTIDROFURILO, POR SALIFICACION DE LA BASE LIBRE, UTILIZANDO ACIDO CITRICO MONOHIDRATADO. CONSISTE EN LA REACCION DE ACETONA, ACETATO DE ETILO, NAFTIDROFURILO BASE Y ACIDO CITRICO MONOHIDRATADO, EN PROPORCION VOLUMETRICA DE ACETONA Y ACETATO DE ETILO 1:1, Y EN PROPORCIONES EQUIMOLECULARES DE NAFTIDROFURILO Y ACIDO CITRICO. LA MEZCLA DE REACCION SE SOMETE A CALENTAMIENTO A REFLUJO; POSTERIORMENTE SE ENFRIA A 5 C Y EL PRODUCTO OBTENIDO SE SEPARA POR FILTRACION. ESTE COMPUESTO TIENE APLICACIONES FARMACOLOGICAS POR SUS EFECTOS CARDIORESPIRATORIOS.
ES512819A 1981-05-14 1982-05-14 "procedimiento para la fabricacion de sales de naftidrofurilo". Expired ES8304559A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8109590A FR2505836A1 (fr) 1981-05-14 1981-05-14 Citrate de naftidrofuryl et son application therapeutique

Publications (2)

Publication Number Publication Date
ES512819A0 ES512819A0 (es) 1983-03-01
ES8304559A1 true ES8304559A1 (es) 1983-03-01

Family

ID=9258433

Family Applications (1)

Application Number Title Priority Date Filing Date
ES512819A Expired ES8304559A1 (es) 1981-05-14 1982-05-14 "procedimiento para la fabricacion de sales de naftidrofurilo".

Country Status (22)

Country Link
US (1) US4439442A (es)
EP (1) EP0065446B1 (es)
JP (1) JPS57203078A (es)
KR (1) KR830010091A (es)
AT (1) ATE9342T1 (es)
AU (1) AU8373282A (es)
CA (1) CA1184562A (es)
CS (1) CS239923B2 (es)
DD (1) DD202432A5 (es)
DE (1) DE3260712D1 (es)
DK (1) DK210982A (es)
ES (1) ES8304559A1 (es)
FI (1) FI821664A7 (es)
FR (1) FR2505836A1 (es)
GR (1) GR75422B (es)
HU (1) HU187701B (es)
IL (1) IL65774A (es)
NZ (1) NZ200594A (es)
PT (1) PT74893B (es)
SU (1) SU1082323A3 (es)
YU (1) YU103082A (es)
ZA (1) ZA823195B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2580502B1 (fr) * 1985-04-23 1988-07-08 Lipha Emploi du " naftidrofuryl " dans la preparation d'un medicament
TW200920348A (en) * 2007-06-28 2009-05-16 Dybly Ag Combination of picotamide with nafronyl
US8203109B2 (en) 2009-05-08 2012-06-19 Raytheon Company High energy laser beam director system and method
CN104086515A (zh) * 2014-06-13 2014-10-08 刘博� 萘呋胺酯草酸盐的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL142872C (es) * 1963-03-28
FR3843M (fr) * 1964-03-17 1966-01-17 Lipha Nouvelles bases azotées a propriétés antispasmodique et vasodilatatrice.

Also Published As

Publication number Publication date
ES512819A0 (es) 1983-03-01
US4439442B1 (es) 1987-06-30
PT74893A (fr) 1982-06-01
PT74893B (fr) 1983-12-23
NZ200594A (en) 1985-03-20
EP0065446B1 (fr) 1984-09-12
EP0065446A1 (fr) 1982-11-24
FR2505836A1 (fr) 1982-11-19
SU1082323A3 (ru) 1984-03-23
FI821664A0 (fi) 1982-05-11
KR830010091A (ko) 1983-12-26
CS239923B2 (en) 1986-01-16
ATE9342T1 (de) 1984-09-15
DE3260712D1 (en) 1984-10-18
FR2505836B1 (es) 1984-03-09
IL65774A0 (en) 1982-08-31
DK210982A (da) 1982-11-15
HU187701B (en) 1986-02-28
JPS57203078A (en) 1982-12-13
FI821664L (fi) 1982-11-15
GR75422B (es) 1984-07-16
DD202432A5 (de) 1983-09-14
US4439442A (en) 1984-03-27
ZA823195B (en) 1983-03-30
IL65774A (en) 1985-09-29
YU103082A (en) 1984-08-31
FI821664A7 (fi) 1982-11-15
AU8373282A (en) 1982-11-18
CA1184562A (fr) 1985-03-26

Similar Documents

Publication Publication Date Title
ES8405766A1 (es) Procedimiento para preparar derivados de fenil-1-piperidino-2-propanol
FR2367750A1 (fr) Acid
ES8304559A1 (es) "procedimiento para la fabricacion de sales de naftidrofurilo".
JPS5227721A (en) Process for preparation of substituted phosphonic acid derivatives
ATE82569T1 (de) Herstellung von chinolincarbonsaeuren.
ATE38515T1 (de) Spiro-2-aza-alkan-3-carbonitrile, verfahren zu ihrer herstellung und ihre verwendung.
JPS5524116A (en) Preparation of o-(2, 6-dichloroanilino)-phenylacetic acid
FR2336369A1 (fr) Procede d'obtention d'acide glutarique, d'acide succinique et d'acide adipique a partir d'un melange acide les contenant ainsi que lesdits acides obtenus par ce procede
US4371705A (en) Synthesis of alpha-amino acids
US4370493A (en) Synthesis of alpha-amino acids
SU513981A1 (ru) Способ получени сульфонилалкиламино- -бисметилфосфоновых кислот
JPS57192340A (en) Isoprenylamine derivative
US2612522A (en) Alkanoyl-alpha-ethylbenzylureas
US2483347A (en) Intermediate products in the production of dialkylamino vitamin a's
ES8104273A1 (es) Un procedimiento para la preparacion de una ftalazina
GB1292846A (en) A process for the synthesis of leupeptins and their analogues
US3897465A (en) Ethyl beta-(N-methylfurfurylamino) propionate
SU1477729A1 (ru) Способ получени 4-гидрокси-8-карбоксихинолона-2
JPS5212146A (en) Process for preparation of p- acetylaminobenzene-sufonylchloride
JPS54157566A (en) Preparation of nucleoside
JPS5257142A (en) Process for preparing dihalovinyl-cyclopropanecarboxylic acid derivati ves
SU584002A1 (ru) Способ получени иодистого бетаина
US3373184A (en) Sulfamide derivatives
ES486298A1 (es) Un procedimiento para la preparacion de 2-metil-3-(b-hidro- ximetilcarbamoil)quinoxalina 1,4-di-n-oxido de gran pureza
SU461103A1 (ru) Способ получени мононатриевой соли -( -тиоэтил-2-амино)-тиофосфорной кислоты